Johnson & Johnson Form 4 insider transactions
NYSE
Director Eugene A. Woods reports acquisition of deferred share units in Johnson & Johnson under the company's Amended and Restated Deferred Fee Plan for Directors.
NYSE
Director Marillyn A. Hewson acquired deferred share units (DSUs) of Johnson & Johnson related to director fees.
NYSE
Johnson & Johnson reports transactions involving CVRx, Inc. common stock and derivative securities, including warrant exercises and stock option acquisitions, through its subsidiary Johnson & Johnson Innovation JJDC, Inc.